data_1jaa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jaa _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.723 0.773 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.458 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 mm -132.16 95.47 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -129.26 80.95 2.0 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.91 53.7 17.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -74.74 -39.08 62.07 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 -66.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.051 1.881 . . . . 0.0 110.112 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 86.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 -151.72 64.87 0.86 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.82 79.37 0.25 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -81.17 73.0 8.23 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.6 m -136.82 -77.25 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 124.421 2.058 . . . . 0.0 110.537 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.15 110.47 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.66 9.38 25.02 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.52 83.72 0.38 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -83.28 76.99 9.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -72.8 -65.01 0.85 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.382 -0.824 . . . . 0.0 111.902 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.369 2.033 . . . . 0.0 109.077 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.75 131.65 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -94.56 65.18 3.13 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.719 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 82.81 0.31 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -84.7 66.1 9.42 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.3 m -143.2 -76.95 0.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.254 1.978 . . . . 0.0 110.709 -179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.0 mm -124.41 136.61 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -127.71 63.15 1.38 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.79 89.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SET . . . . . 0.444 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 5' ' ' SET . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -88.98 74.01 8.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -133.19 -84.46 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.285 1.993 . . . . 0.0 109.996 -179.54 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -109.14 113.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.458 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -148.04 114.71 6.02 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.14 83.84 0.35 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.458 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -82.23 60.48 5.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.6 m -148.37 -74.53 0.18 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 124.398 2.047 . . . . 0.0 107.927 178.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.77 141.45 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.48 136.61 54.93 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.79 87.16 0.1 Allowed Glycine 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -83.8 72.96 10.35 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.8 m -135.11 -72.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 124.317 2.008 . . . . 0.0 110.894 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.2 102.2 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -162.81 127.65 3.14 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.33 86.14 0.34 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -81.93 70.61 8.88 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -136.56 -76.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 124.248 1.975 . . . . 0.0 109.92 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -114.08 120.72 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.64 109.49 5.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.69 82.16 0.37 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -78.57 74.23 5.11 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -83.53 -69.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.877 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 124.397 2.046 . . . . 0.0 110.007 179.613 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.1 mm -119.57 106.01 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -156.58 132.99 9.99 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 92.82 0.13 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -79.56 81.73 5.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -66.12 -59.44 3.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.501 -0.75 . . . . 0.0 112.572 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.805 1.288 . . . . 0.0 109.788 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.1 95.04 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -168.79 135.18 1.81 Allowed 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.67 95.44 0.23 Allowed Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -157.43 74.99 0.78 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.9 m -139.06 -74.12 0.38 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.754 -1.216 . . . . 0.0 108.354 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 124.376 2.036 . . . . 0.0 110.568 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -122.51 103.98 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -74.6 -35.01 62.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.72 82.51 0.52 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -148.11 -73.73 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 m -114.6 88.69 2.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 124.156 1.931 . . . . 0.0 110.82 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.61 121.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.99 38.42 4.19 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.49 77.68 0.55 Allowed Glycine 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -82.62 -68.43 0.7 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.8 m -145.26 112.02 5.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.165 1.936 . . . . 0.0 108.811 179.525 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.77 119.56 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.88 30.3 5.95 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.1 89.94 0.21 Allowed Glycine 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -139.8 -77.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.169 1.937 . . . . 0.0 108.356 179.901 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.51 114.5 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -119.26 23.62 11.2 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.95 18.08 Favored Glycine 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -148.23 -72.09 0.2 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.5 m -130.56 101.39 5.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 124.113 1.911 . . . . 0.0 108.299 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.1 mm -113.32 116.16 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.68 25.16 8.23 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.41 90.17 0.25 Allowed Glycine 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -151.2 -76.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -137.69 108.86 6.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 122.965 1.364 . . . . 0.0 111.362 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.85 119.24 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -122.47 42.54 3.13 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.68 75.05 0.87 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -96.17 -73.46 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.3 m -147.37 109.98 4.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 123.026 1.393 . . . . 0.0 110.09 179.723 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -112.85 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.88 24.12 9.14 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.31 86.51 0.29 Allowed Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m -148.48 -75.69 0.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.6 m -139.1 107.45 5.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.901 1.334 . . . . 0.0 111.497 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.76 116.05 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -110.17 71.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 64.43 1.92 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -79.6 -65.46 1.0 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 m -142.19 110.45 6.0 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 122.947 1.356 . . . . 0.0 110.912 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.12 119.84 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -119.24 58.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.09 65.15 1.78 Allowed Glycine 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -98.23 -66.7 0.89 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 m -75.26 130.09 38.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 118.775 0.716 . . . . 0.0 110.722 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.896 1.332 . . . . 0.0 113.57 -179.821 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.84 116.25 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.92 24.44 8.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -177.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.81 91.3 0.25 Allowed Glycine 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m -148.61 -75.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -137.79 107.77 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 124.121 1.915 . . . . 0.0 110.343 179.909 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.97 89.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 -116.38 73.09 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.57 96.36 0.52 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -72.3 -61.4 1.81 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 p -94.86 74.81 3.59 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.38 0.991 . . . . 0.0 110.479 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.856 1.313 . . . . 0.0 111.772 -179.397 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.8 82.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -155.67 78.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.93 96.93 1.33 Allowed Glycine 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -77.5 -70.75 0.45 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 p -110.11 71.91 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.333 2.016 . . . . 0.0 110.433 -179.156 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.39 114.43 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.28 11.47 25.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.98 87.88 0.47 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -138.7 -76.51 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.3 p -111.41 -51.7 2.84 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 119.18 0.9 . . . . 0.0 113.174 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 124.338 2.018 . . . . 0.0 113.069 -178.882 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.15 117.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.46 52.4 1.52 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.11 91.91 0.12 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m -137.08 -81.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 p -109.41 -69.01 0.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.855 0.862 . . . . 0.0 109.92 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.38 2.038 . . . . 0.0 108.224 179.784 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.25 114.1 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -118.63 13.99 13.46 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 92.34 0.53 Allowed Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -134.82 -82.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.4 p -128.94 -56.2 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.09 0.956 . . . . 0.0 111.307 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.828 1.299 . . . . 0.0 113.784 179.798 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.254 0.9 OUTLIER -109.49 114.69 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 . . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -110.45 10.88 23.25 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.94 86.62 0.45 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -141.4 -80.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.6 p -95.18 -61.14 1.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.128 0.876 . . . . 0.0 112.265 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.849 1.309 . . . . 0.0 110.042 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.86 115.7 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -117.35 12.8 14.39 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.99 92.56 0.52 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m -138.4 -81.5 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.8 p -111.63 -64.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.829 0.851 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.823 1.297 . . . . 0.0 110.396 -179.769 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.26 99.68 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -102.81 92.46 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.37 84.77 0.12 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -61.48 -52.95 62.4 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.7 m -132.46 97.88 4.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 124.114 1.912 . . . . 0.0 111.294 -179.789 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.241 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -118.73 99.92 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -101.62 92.12 4.73 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.38 85.68 0.11 Allowed Glycine 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -61.46 -54.7 39.95 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -132.13 98.45 4.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.163 1.935 . . . . 0.0 111.223 -179.854 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -118.64 99.67 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -101.5 92.15 4.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.91 85.05 0.12 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -61.66 -53.5 55.27 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -133.56 98.58 4.24 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.199 1.952 . . . . 0.0 111.1 -179.796 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -119.19 102.21 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -104.44 92.82 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.71 79.82 0.19 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -58.72 -53.35 59.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 98.12 4.12 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.445 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.123 1.916 . . . . 0.0 111.223 -179.795 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.93 85.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.37 1.044 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -120.53 72.72 0.97 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 176.191 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.06 -79.59 1.48 Allowed Glycine 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m -108.84 -78.45 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -124.18 -79.31 0.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 123.107 1.432 . . . . 0.0 109.244 179.518 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.54 112.19 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -83.44 84.11 7.64 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.58 -79.67 1.54 Allowed Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -131.91 -77.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 p -113.34 -80.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.476 1.035 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 123.007 1.384 . . . . 0.0 112.954 -179.348 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.35 109.32 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.46 83.17 8.01 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 178.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.41 -78.92 1.6 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -134.97 -76.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.9 p -119.56 -80.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.635 1.107 . . . . 0.0 109.372 179.396 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 124.394 2.045 . . . . 0.0 111.107 -179.356 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.68 91.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -82.25 -36.99 26.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 75.76 0.06 OUTLIER Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -148.88 -73.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -86.48 120.36 27.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 123.036 1.398 . . . . 0.0 113.379 -179.771 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.75 90.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -77.13 -34.02 56.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.63 79.28 0.04 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -151.19 -70.88 0.17 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 95.7 m -145.4 101.77 3.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 122.955 1.359 . . . . 0.0 111.322 179.999 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.23 99.21 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -85.2 -37.58 19.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -177.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.35 91.73 2.03 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m -143.49 -78.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -145.98 100.79 3.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.408 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 124.336 2.017 . . . . 0.0 108.769 -179.961 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -127.15 95.27 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.46 61.61 1.47 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.06 92.97 0.1 Allowed Glycine 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m -149.88 -82.98 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -151.36 110.01 3.83 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 123.002 1.382 . . . . 0.0 111.72 -179.829 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.67 99.19 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -83.81 -37.74 22.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -177.79 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.11 83.17 1.3 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -145.96 -74.35 0.22 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.1 m -143.69 101.91 3.84 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 179.119 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 124.147 1.927 . . . . 0.0 110.215 -179.952 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.75 102.63 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -128.12 77.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 179.037 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.17 85.33 0.09 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m -126.88 -78.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -140.07 92.47 2.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 179.592 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.943 1.354 . . . . 0.0 109.918 179.85 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.23 94.83 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -119.86 72.02 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 178.375 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.1 92.98 0.08 OUTLIER Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m -108.41 -79.06 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.2 m -145.97 118.72 8.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.759 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 122.899 1.333 . . . . 0.0 109.614 179.584 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.57 91.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -94.89 -2.24 51.05 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -179.15 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.51 85.88 0.16 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -87.02 -81.85 0.22 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -147.59 135.47 21.15 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.339 0.972 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 123.064 1.411 . . . . 0.0 112.316 179.407 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.57 109.9 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -83.62 -23.2 31.97 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 179.549 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.29 -78.43 0.96 Allowed Glycine 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -157.57 -78.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -77.4 132.16 38.38 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.751 0.82 . . . . 0.0 110.702 -179.081 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -179.569 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.65 117.32 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -73.25 -36.08 66.33 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 178.639 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.08 -76.55 1.82 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m -135.88 -86.18 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 m -134.7 141.54 46.56 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.758 1.163 . . . . 0.0 110.425 -177.792 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 122.769 1.271 . . . . 0.0 113.42 179.723 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.87 116.6 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -72.36 -33.09 67.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.01 -75.33 1.07 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m -142.71 -84.31 0.17 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 m -137.45 144.73 42.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 119.731 1.151 . . . . 0.0 110.533 -177.719 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 122.813 1.292 . . . . 0.0 113.203 179.436 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.73 108.71 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -77.96 -18.72 55.69 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 179.01 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.49 -78.64 0.24 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p -143.99 -86.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.9 m -149.17 137.11 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.329 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.981 1.372 . . . . 0.0 112.197 179.032 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.06 116.1 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.89 -34.15 64.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.07 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.83 -75.23 0.94 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m -141.93 -83.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 143.92 43.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 119.669 1.122 . . . . 0.0 110.608 -177.686 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.798 1.285 . . . . 0.0 113.256 179.491 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.72 111.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -89.57 -40.64 12.49 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -179.161 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.28 60.51 8.9 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -56.08 -41.22 74.79 Favored 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.1 p -68.52 -46.88 68.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 178.748 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 179.288 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.3 109.58 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -85.9 -15.72 40.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -179.718 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.42 1.38 Allowed Glycine 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m -68.12 -63.73 1.0 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.4 p -98.48 87.94 3.98 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.156 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.371 2.034 . . . . 0.0 110.587 -179.378 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.723 0.773 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.434 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 mm -132.16 95.47 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -129.26 80.95 2.0 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.91 53.7 17.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -74.74 -39.08 62.07 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 -66.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.051 1.881 . . . . 0.0 110.112 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 86.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 -151.72 64.87 0.86 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.82 79.37 0.25 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -81.17 73.0 8.23 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.6 m -136.82 -77.25 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 124.421 2.058 . . . . 0.0 110.537 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.15 110.47 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.66 9.38 25.02 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.52 83.72 0.38 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -83.28 76.99 9.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -72.8 -65.01 0.85 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.382 -0.824 . . . . 0.0 111.902 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.369 2.033 . . . . 0.0 109.077 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.75 131.65 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -94.56 65.18 3.13 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.719 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 82.81 0.31 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -84.7 66.1 9.42 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.3 m -143.2 -76.95 0.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.254 1.978 . . . . 0.0 110.709 -179.681 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.0 mm -124.41 136.61 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -127.71 63.15 1.38 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.79 89.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -88.98 74.01 8.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -133.19 -84.46 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.285 1.993 . . . . 0.0 109.996 -179.54 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -109.14 113.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.434 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -148.04 114.71 6.02 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.14 83.84 0.35 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -82.23 60.48 5.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.6 m -148.37 -74.53 0.18 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 124.398 2.047 . . . . 0.0 107.927 178.883 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.77 141.45 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.48 136.61 54.93 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.79 87.16 0.1 Allowed Glycine 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -83.8 72.96 10.35 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.8 m -135.11 -72.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 124.317 2.008 . . . . 0.0 110.894 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.2 102.2 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -162.81 127.65 3.14 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.33 86.14 0.34 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -81.93 70.61 8.88 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -136.56 -76.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 124.248 1.975 . . . . 0.0 109.92 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -114.08 120.72 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.64 109.49 5.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.69 82.16 0.37 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -78.57 74.23 5.11 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -83.53 -69.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.877 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 124.397 2.046 . . . . 0.0 110.007 179.613 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.1 mm -119.57 106.01 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -156.58 132.99 9.99 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 92.82 0.13 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -79.56 81.73 5.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -66.12 -59.44 3.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.501 -0.75 . . . . 0.0 112.572 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.805 1.288 . . . . 0.0 109.788 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.1 95.04 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -168.79 135.18 1.81 Allowed 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.67 95.44 0.23 Allowed Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -157.43 74.99 0.78 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.9 m -139.06 -74.12 0.38 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.754 -1.216 . . . . 0.0 108.354 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 124.376 2.036 . . . . 0.0 110.568 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -122.51 103.98 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -74.6 -35.01 62.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.72 82.51 0.52 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -148.11 -73.73 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 m -114.6 88.69 2.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 124.156 1.931 . . . . 0.0 110.82 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.61 121.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.99 38.42 4.19 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.49 77.68 0.55 Allowed Glycine 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -82.62 -68.43 0.7 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.8 m -145.26 112.02 5.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.165 1.936 . . . . 0.0 108.811 179.525 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.77 119.56 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.88 30.3 5.95 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.1 89.94 0.21 Allowed Glycine 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -139.8 -77.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.169 1.937 . . . . 0.0 108.356 179.901 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.51 114.5 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -119.26 23.62 11.2 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.95 18.08 Favored Glycine 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -148.23 -72.09 0.2 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.5 m -130.56 101.39 5.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 124.113 1.911 . . . . 0.0 108.299 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.1 mm -113.32 116.16 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.68 25.16 8.23 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.41 90.17 0.25 Allowed Glycine 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -151.2 -76.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -137.69 108.86 6.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 122.965 1.364 . . . . 0.0 111.362 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.85 119.24 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -122.47 42.54 3.13 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.68 75.05 0.87 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -96.17 -73.46 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.3 m -147.37 109.98 4.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 123.026 1.393 . . . . 0.0 110.09 179.723 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -112.85 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.88 24.12 9.14 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.31 86.51 0.29 Allowed Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m -148.48 -75.69 0.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.6 m -139.1 107.45 5.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.901 1.334 . . . . 0.0 111.497 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.76 116.05 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -110.17 71.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 64.43 1.92 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -79.6 -65.46 1.0 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 m -142.19 110.45 6.0 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 122.947 1.356 . . . . 0.0 110.912 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.12 119.84 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -119.24 58.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.09 65.15 1.78 Allowed Glycine 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -98.23 -66.7 0.89 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 m -75.26 130.09 38.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 118.775 0.716 . . . . 0.0 110.722 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.896 1.332 . . . . 0.0 113.57 -179.821 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.84 116.25 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.92 24.44 8.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -177.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.81 91.3 0.25 Allowed Glycine 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m -148.61 -75.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -137.79 107.77 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 124.121 1.915 . . . . 0.0 110.343 179.909 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.97 89.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 -116.38 73.09 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.57 96.36 0.52 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -72.3 -61.4 1.81 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 p -94.86 74.81 3.59 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.38 0.991 . . . . 0.0 110.479 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.856 1.313 . . . . 0.0 111.772 -179.397 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.8 82.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -155.67 78.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.93 96.93 1.33 Allowed Glycine 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -77.5 -70.75 0.45 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 p -110.11 71.91 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.333 2.016 . . . . 0.0 110.433 -179.156 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.39 114.43 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.28 11.47 25.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.98 87.88 0.47 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -138.7 -76.51 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.3 p -111.41 -51.7 2.84 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 119.18 0.9 . . . . 0.0 113.174 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 124.338 2.018 . . . . 0.0 113.069 -178.882 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.15 117.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.46 52.4 1.52 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.11 91.91 0.12 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m -137.08 -81.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 p -109.41 -69.01 0.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.855 0.862 . . . . 0.0 109.92 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.38 2.038 . . . . 0.0 108.224 179.784 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.25 114.1 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -118.63 13.99 13.46 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 92.34 0.53 Allowed Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -134.82 -82.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.4 p -128.94 -56.2 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.09 0.956 . . . . 0.0 111.307 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.828 1.299 . . . . 0.0 113.784 179.798 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.254 0.9 OUTLIER -109.49 114.69 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 . . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -110.45 10.88 23.25 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.94 86.62 0.45 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -141.4 -80.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.6 p -95.18 -61.14 1.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.128 0.876 . . . . 0.0 112.265 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.849 1.309 . . . . 0.0 110.042 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.86 115.7 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -117.35 12.8 14.39 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.99 92.56 0.52 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m -138.4 -81.5 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.8 p -111.63 -64.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.829 0.851 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.823 1.297 . . . . 0.0 110.396 -179.769 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.26 99.68 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -102.81 92.46 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.37 84.77 0.12 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -61.48 -52.95 62.4 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.7 m -132.46 97.88 4.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 124.114 1.912 . . . . 0.0 111.294 -179.789 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.241 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -118.73 99.92 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -101.62 92.12 4.73 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.38 85.68 0.11 Allowed Glycine 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -61.46 -54.7 39.95 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -132.13 98.45 4.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.163 1.935 . . . . 0.0 111.223 -179.854 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -118.64 99.67 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -101.5 92.15 4.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.91 85.05 0.12 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -61.66 -53.5 55.27 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -133.56 98.58 4.24 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.199 1.952 . . . . 0.0 111.1 -179.796 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -119.19 102.21 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -104.44 92.82 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.415 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.71 79.82 0.19 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -58.72 -53.35 59.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 98.12 4.12 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.445 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.123 1.916 . . . . 0.0 111.223 -179.795 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.93 85.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.37 1.044 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -120.53 72.72 0.97 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 176.191 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.06 -79.59 1.48 Allowed Glycine 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m -108.84 -78.45 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -124.18 -79.31 0.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 123.107 1.432 . . . . 0.0 109.244 179.518 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.54 112.19 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -83.44 84.11 7.64 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.58 -79.67 1.54 Allowed Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -131.91 -77.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 p -113.34 -80.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.476 1.035 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 123.007 1.384 . . . . 0.0 112.954 -179.348 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.35 109.32 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.46 83.17 8.01 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 178.766 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.41 -78.92 1.6 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -134.97 -76.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.9 p -119.56 -80.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.635 1.107 . . . . 0.0 109.372 179.396 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 124.394 2.045 . . . . 0.0 111.107 -179.356 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.68 91.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -82.25 -36.99 26.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 75.76 0.06 OUTLIER Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -148.88 -73.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -86.48 120.36 27.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 123.036 1.398 . . . . 0.0 113.379 -179.771 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.75 90.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -77.13 -34.02 56.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.63 79.28 0.04 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -151.19 -70.88 0.17 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 95.7 m -145.4 101.77 3.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 122.955 1.359 . . . . 0.0 111.322 179.999 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.23 99.21 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -85.2 -37.58 19.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -177.705 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.35 91.73 2.03 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m -143.49 -78.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -145.98 100.79 3.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.408 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 124.336 2.017 . . . . 0.0 108.769 -179.961 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -127.15 95.27 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.46 61.61 1.47 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.06 92.97 0.1 Allowed Glycine 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m -149.88 -82.98 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -151.36 110.01 3.83 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 123.002 1.382 . . . . 0.0 111.72 -179.829 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.67 99.19 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -83.81 -37.74 22.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -177.79 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.11 83.17 1.3 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -145.96 -74.35 0.22 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.1 m -143.69 101.91 3.84 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 179.119 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 124.147 1.927 . . . . 0.0 110.215 -179.952 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.75 102.63 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -128.12 77.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 179.037 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.17 85.33 0.09 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m -126.88 -78.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -140.07 92.47 2.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 179.592 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.943 1.354 . . . . 0.0 109.918 179.85 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.23 94.83 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -119.86 72.02 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 178.375 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.1 92.98 0.08 OUTLIER Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m -108.41 -79.06 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.2 m -145.97 118.72 8.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.759 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 122.899 1.333 . . . . 0.0 109.614 179.584 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.57 91.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -94.89 -2.24 51.05 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -179.15 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.51 85.88 0.16 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -87.02 -81.85 0.22 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -147.59 135.47 21.15 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.339 0.972 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 123.064 1.411 . . . . 0.0 112.316 179.407 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.57 109.9 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -83.62 -23.2 31.97 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 179.549 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.29 -78.43 0.96 Allowed Glycine 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -157.57 -78.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -77.4 132.16 38.38 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.751 0.82 . . . . 0.0 110.702 -179.081 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -179.569 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.65 117.32 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -73.25 -36.08 66.33 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 178.639 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.08 -76.55 1.82 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m -135.88 -86.18 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 m -134.7 141.54 46.56 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.758 1.163 . . . . 0.0 110.425 -177.792 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 122.769 1.271 . . . . 0.0 113.42 179.723 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.87 116.6 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -72.36 -33.09 67.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.01 -75.33 1.07 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m -142.71 -84.31 0.17 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 m -137.45 144.73 42.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 119.731 1.151 . . . . 0.0 110.533 -177.719 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 122.813 1.292 . . . . 0.0 113.203 179.436 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.73 108.71 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -77.96 -18.72 55.69 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 179.01 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.49 -78.64 0.24 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p -143.99 -86.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.9 m -149.17 137.11 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.329 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.981 1.372 . . . . 0.0 112.197 179.032 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.06 116.1 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.89 -34.15 64.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.07 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.83 -75.23 0.94 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m -141.93 -83.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 143.92 43.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 119.669 1.122 . . . . 0.0 110.608 -177.686 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.798 1.285 . . . . 0.0 113.256 179.491 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.72 111.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -89.57 -40.64 12.49 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -179.161 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.28 60.51 8.9 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -56.08 -41.22 74.79 Favored 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.1 p -68.52 -46.88 68.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 178.748 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 179.288 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.3 109.58 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -85.9 -15.72 40.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -179.718 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.42 1.38 Allowed Glycine 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m -68.12 -63.73 1.0 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.4 p -98.48 87.94 3.98 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.156 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.371 2.034 . . . . 0.0 110.587 -179.378 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.723 0.773 . . . . 0.0 112.719 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.434 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 . . . . . 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.2 mm -132.16 95.47 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -129.26 80.95 2.0 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.91 53.7 17.11 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.689 2.635 . . . . 0.0 119.689 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.56 -68.14 0.67 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -94.11 91.95 7.06 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -84.5 64.11 8.24 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.156 0.979 . . . . 0.0 112.592 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 81.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -138.95 97.53 3.34 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -74.74 -39.08 62.07 Favored 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.433 1.47 . . . . 0.0 113.852 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -125.62 -66.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 124.051 1.881 . . . . 0.0 110.112 179.281 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 86.82 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.295 36.4 p-90 -151.72 64.87 0.86 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 122.612 1.196 . . . . 0.0 112.12 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.82 79.37 0.25 Allowed Glycine 0 N--CA 1.481 1.676 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.407 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.09 -81.17 1.3 Allowed Glycine 0 N--CA 1.481 1.671 0 CA-C-N 116.514 -0.312 . . . . 0.0 112.983 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.1 103.96 13.55 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.68 103.68 5.06 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.873 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.87 73.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.392 0.677 . . . . 0.0 109.64 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.82 55.78 0.73 Allowed 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 110.163 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.4 m -81.17 73.0 8.23 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.596 -1.315 . . . . 0.0 111.55 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.6 m -136.82 -77.25 0.41 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 124.421 2.058 . . . . 0.0 110.537 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.15 110.47 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -109.66 9.38 25.02 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.52 83.72 0.38 Allowed Glycine 0 N--CA 1.481 1.637 0 CA-C-N 119.726 1.148 . . . . 0.0 113.406 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.36 -81.24 1.05 Allowed Glycine 0 N--CA 1.482 1.73 0 C-N-CA 122.916 0.293 . . . . 0.0 112.92 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 107.87 17.56 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.87 93.81 3.8 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.41 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -150.38 81.33 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.466 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -150.71 72.71 1.09 Allowed 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -83.28 76.99 9.85 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.471 -1.393 . . . . 0.0 110.428 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -72.8 -65.01 0.85 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.382 -0.824 . . . . 0.0 111.902 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.369 2.033 . . . . 0.0 109.077 179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.75 131.65 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 -94.56 65.18 3.13 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.719 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 82.81 0.31 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.68 -80.71 1.02 Allowed Glycine 0 N--CA 1.482 1.715 0 C-N-CA 122.837 0.256 . . . . 0.0 113.185 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.97 100.17 9.94 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.62 87.53 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.207 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -156.91 83.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.476 0.71 . . . . 0.0 109.201 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.42 90.51 2.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -84.7 66.1 9.42 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.932 1.697 . . . . 0.0 110.724 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.3 m -143.2 -76.95 0.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.254 1.978 . . . . 0.0 110.709 -179.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.0 mm -124.41 136.61 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -127.71 63.15 1.38 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.041 0.924 . . . . 0.0 109.959 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.79 89.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.494 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.62 -80.21 1.03 Allowed Glycine 0 N--CA 1.482 1.754 0 C-N-CA 122.704 0.192 . . . . 0.0 112.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.33 110.81 20.49 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -76.08 94.31 3.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.677 0.791 . . . . 0.0 109.114 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.3 tp -151.94 80.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.431 0.692 . . . . 0.0 109.456 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 52.66 1.0 Allowed 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.556 -0.715 . . . . 0.0 111.084 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -88.98 74.01 8.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.893 -1.129 . . . . 0.0 109.899 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -133.19 -84.46 0.46 Allowed 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 124.285 1.993 . . . . 0.0 109.996 -179.54 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.5 mm -109.14 113.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.434 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -148.04 114.71 6.02 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.14 83.84 0.35 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.88 -80.97 1.21 Allowed Glycine 0 N--CA 1.483 1.815 0 C-N-CA 122.735 0.207 . . . . 0.0 113.496 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 101.74 11.58 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.77 90.64 4.04 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.644 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -151.32 76.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.168 0.985 . . . . 0.0 109.848 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 3' ' ' TRP . 1.0 OUTLIER -149.74 95.17 2.28 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -82.23 60.48 5.0 Favored 'General case' 0 N--CA 1.51 2.531 0 CA-C-N 121.949 2.159 . . . . 0.0 112.248 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.6 m -148.37 -74.53 0.18 Allowed 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 124.398 2.047 . . . . 0.0 107.927 178.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -119.77 141.45 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -122.48 136.61 54.93 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 123.127 1.441 . . . . 0.0 110.08 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.79 87.16 0.1 Allowed Glycine 0 CA--C 1.539 1.539 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.7 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.74 -80.27 1.37 Allowed Glycine 0 N--CA 1.483 1.799 0 C-N-CA 122.779 0.228 . . . . 0.0 112.983 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -107.23 106.77 17.4 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.52 101.79 5.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -148.47 71.42 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.52 0 C-N-CA 123.595 0.758 . . . . 0.0 109.196 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.35 61.76 0.49 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 123.741 0.816 . . . . 0.0 109.519 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 m -83.8 72.96 10.35 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 120.155 -1.591 . . . . 0.0 110.997 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.8 m -135.11 -72.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 124.317 2.008 . . . . 0.0 110.894 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -112.2 102.2 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.1 p-90 -162.81 127.65 3.14 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.33 86.14 0.34 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 114.671 -1.15 . . . . 0.0 114.176 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.06 -80.26 0.78 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -104.77 106.68 17.27 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.37 87.48 4.4 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.041 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -153.05 79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.38 70.62 1.18 Allowed 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -81.93 70.61 8.88 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.689 -1.257 . . . . 0.0 111.376 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -136.56 -76.05 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 124.248 1.975 . . . . 0.0 109.92 179.857 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -114.08 120.72 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.64 109.49 5.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.69 82.16 0.37 Allowed Glycine 0 N--CA 1.479 1.552 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.968 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.38 -81.48 1.05 Allowed Glycine 0 N--CA 1.48 1.621 0 C-N-CA 122.832 0.253 . . . . 0.0 112.521 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -108.53 108.19 19.01 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.9 mp -77.31 90.41 3.76 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.662 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -151.29 81.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 123.315 0.646 . . . . 0.0 110.006 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.71 76.88 1.36 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -78.57 74.23 5.11 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.617 -1.302 . . . . 0.0 111.038 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.9 m -83.53 -69.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.877 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 124.397 2.046 . . . . 0.0 110.007 179.613 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.1 mm -119.57 106.01 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -156.58 132.99 9.99 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-O 122.325 1.059 . . . . 0.0 109.48 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 92.82 0.13 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.13 -80.92 1.42 Allowed Glycine 0 N--CA 1.483 1.792 0 C-N-CA 122.828 0.251 . . . . 0.0 113.217 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -103.6 106.77 17.37 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.13 98.49 5.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -143.68 71.54 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.481 0 CA-C-O 121.889 0.852 . . . . 0.0 109.358 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.26 67.44 0.66 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -79.56 81.73 5.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.386 -1.446 . . . . 0.0 110.219 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 m -66.12 -59.44 3.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.501 -0.75 . . . . 0.0 112.572 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 122.805 1.288 . . . . 0.0 109.788 179.37 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -112.1 95.04 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -168.79 135.18 1.81 Allowed 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.67 95.44 0.23 Allowed Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.397 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.95 -80.85 1.32 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 122.933 0.301 . . . . 0.0 113.657 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -103.34 106.35 16.85 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.5 90.34 5.08 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.378 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -145.67 70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.493 0.717 . . . . 0.0 110.4 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.55 36.05 1.65 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -157.43 74.99 0.78 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.9 m -139.06 -74.12 0.38 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.754 -1.216 . . . . 0.0 108.354 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 124.376 2.036 . . . . 0.0 110.568 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -122.51 103.98 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -74.6 -35.01 62.98 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.72 82.51 0.52 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 106.439 -2.665 . . . . 0.0 106.439 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.907 0.384 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.66 -77.98 1.05 Allowed Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -89.07 91.29 8.76 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -79.99 90.14 5.36 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.14 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 tp -145.93 79.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -101.17 41.13 1.21 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -148.11 -73.73 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 m -114.6 88.69 2.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 124.156 1.931 . . . . 0.0 110.82 -179.517 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.61 121.45 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.99 38.42 4.19 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.49 77.68 0.55 Allowed Glycine 0 N--CA 1.484 1.835 0 O-C-N 121.389 -0.819 . . . . 0.0 114.485 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.168 0.509 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.35 -78.69 1.21 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -95.89 89.98 5.45 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.1 98.19 4.96 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.707 0.765 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -145.84 77.65 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -96.92 69.93 2.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -82.62 -68.43 0.7 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.015 -1.053 . . . . 0.0 111.204 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.8 m -145.26 112.02 5.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.165 1.936 . . . . 0.0 108.811 179.525 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.77 119.56 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.88 30.3 5.95 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.1 89.94 0.21 Allowed Glycine 0 N--CA 1.485 1.955 0 O-C-N 121.052 -1.03 . . . . 0.0 112.354 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.29 -79.25 0.66 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 98.03 10.71 Favored 'General case' 0 CA--C 1.555 1.154 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 176.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.4 107.99 12.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 tp -118.05 60.31 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.0 58.55 0.85 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.453 1.101 . . . . 0.0 110.007 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -139.8 -77.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -137.05 102.95 4.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.169 1.937 . . . . 0.0 108.356 179.901 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 mm -110.51 114.5 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -119.26 23.62 11.2 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.95 18.08 Favored Glycine 0 CA--C 1.55 2.276 0 O-C-N 120.908 -1.12 . . . . 0.0 114.31 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.82 -80.21 0.8 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 92.46 7.56 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.7 mt -74.67 105.1 5.6 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.596 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -141.38 73.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -102.25 58.88 0.82 Allowed 'General case' 0 CA--C 1.573 1.835 0 O-C-N 121.904 -0.497 . . . . 0.0 110.423 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -148.23 -72.09 0.2 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.98 -1.075 . . . . 0.0 108.385 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.5 m -130.56 101.39 5.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 124.113 1.911 . . . . 0.0 108.299 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.1 mm -113.32 116.16 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -123.68 25.16 8.23 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.41 90.17 0.25 Allowed Glycine 0 N--CA 1.488 2.116 0 O-C-N 120.945 -1.097 . . . . 0.0 111.257 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.81 -78.14 0.7 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 91.4 7.66 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -75.97 104.14 6.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -120.88 62.04 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.49 55.48 0.71 Allowed 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 124.25 1.02 . . . . 0.0 110.853 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -151.2 -76.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -137.69 108.86 6.8 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 122.965 1.364 . . . . 0.0 111.362 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.263 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.3 mm -112.85 119.24 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -122.47 42.54 3.13 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.68 75.05 0.87 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.511 -0.743 . . . . 0.0 113.98 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.53 -75.06 0.74 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.07 92.12 8.58 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.81 104.57 3.47 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.17 64.36 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.44 67.35 0.74 Allowed 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.116 0.967 . . . . 0.0 109.995 -178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -96.17 -73.46 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.3 m -147.37 109.98 4.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 123.026 1.393 . . . . 0.0 110.09 179.723 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.234 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -112.85 115.88 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.88 24.12 9.14 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.31 86.51 0.29 Allowed Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.917 -1.114 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.41 -78.22 0.65 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.64 91.76 5.57 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 176.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.32 104.01 4.2 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -117.34 62.29 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 53.96 0.71 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.262 1.025 . . . . 0.0 111.26 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.7 m -148.48 -75.69 0.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.6 m -139.1 107.45 5.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.901 1.334 . . . . 0.0 111.497 179.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -117.76 116.05 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -110.17 71.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.361 1.076 . . . . 0.0 111.339 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 64.43 1.92 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.25 -77.88 0.45 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -94.18 89.25 5.91 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -76.98 98.6 5.0 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.337 0.655 . . . . 0.0 111.555 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.57 54.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 123.856 0.863 . . . . 0.0 109.341 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -127.82 77.91 1.79 Allowed 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -79.6 -65.46 1.0 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.826 -1.171 . . . . 0.0 111.356 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.5 m -142.19 110.45 6.0 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 122.947 1.356 . . . . 0.0 110.912 179.705 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.12 119.84 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -119.24 58.5 0.86 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.139 0.971 . . . . 0.0 110.553 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.09 65.15 1.78 Allowed Glycine 0 CA--C 1.545 1.951 0 CA-C-N 115.439 -0.801 . . . . 0.0 115.098 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.8 -78.43 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -89.9 91.78 8.74 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.6 mt -75.74 97.87 3.96 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.46 70.8 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.6 70.69 0.74 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 124.276 1.03 . . . . 0.0 109.135 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -98.23 -66.7 0.89 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 m -75.26 130.09 38.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 118.775 0.716 . . . . 0.0 110.722 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 122.896 1.332 . . . . 0.0 113.57 -179.821 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.84 116.25 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -122.92 24.44 8.99 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -177.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.81 91.3 0.25 Allowed Glycine 0 N--CA 1.485 1.966 0 O-C-N 120.811 -1.18 . . . . 0.0 111.228 -179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.67 -77.93 0.71 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -177.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -89.18 89.88 8.13 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 104.267 -2.494 . . . . 0.0 104.267 176.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -77.77 103.36 7.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 tp -123.97 62.77 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.2 53.35 0.76 Allowed 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.361 1.064 . . . . 0.0 111.346 -178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.3 m -148.61 -75.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -137.79 107.77 6.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 124.121 1.915 . . . . 0.0 110.343 179.909 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.97 89.02 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . 0.26 56.4 p-90 -116.38 73.09 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.858 1.313 . . . . 0.0 108.835 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.57 96.36 0.52 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.035 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.39 -77.22 1.96 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -178.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.54 90.9 8.59 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 176.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.7 mt -83.4 83.92 7.7 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 122.164 0.983 . . . . 0.0 113.469 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -110.14 76.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 176.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -101.41 69.74 1.27 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 122.995 0.518 . . . . 0.0 110.612 -175.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -72.3 -61.4 1.81 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.285 -0.884 . . . . 0.0 113.223 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 p -94.86 74.81 3.59 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.38 0.991 . . . . 0.0 110.479 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 122.856 1.313 . . . . 0.0 111.772 -179.397 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.8 82.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -155.67 78.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.93 96.93 1.33 Allowed Glycine 0 CA--C 1.54 1.628 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.435 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.66 -69.86 2.19 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -177.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -86.94 91.49 8.7 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 175.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -99.15 100.6 11.74 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -175.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 tp -142.11 77.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 N-CA-C 100.372 -3.936 . . . . 0.0 100.372 175.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.27 66.57 1.78 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -174.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.9 m -77.5 -70.75 0.45 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.255 -0.903 . . . . 0.0 109.033 178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 p -110.11 71.91 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.333 2.016 . . . . 0.0 110.433 -179.156 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.39 114.43 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.28 11.47 25.32 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.98 87.88 0.47 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 177.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -78.3 0.82 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.4 93.41 9.3 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 176.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.54 92.53 5.93 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.23 1.014 . . . . 0.0 112.921 -177.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.19 79.58 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 178.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -91.61 63.09 4.65 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -138.7 -76.51 0.37 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.3 p -111.41 -51.7 2.84 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 119.18 0.9 . . . . 0.0 113.174 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 124.338 2.018 . . . . 0.0 113.069 -178.882 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.15 117.24 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -124.46 52.4 1.52 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.486 1.136 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.11 91.91 0.12 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 178.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -76.89 0.54 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -94.18 93.69 7.93 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mp -78.1 97.58 5.48 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.054 0.93 . . . . 0.0 112.555 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.62 77.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 178.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -101.93 67.92 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -176.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 m -137.08 -81.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 p -109.41 -69.01 0.88 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.855 0.862 . . . . 0.0 109.92 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.38 2.038 . . . . 0.0 108.224 179.784 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -128.25 114.1 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -118.63 13.99 13.46 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 92.34 0.53 Allowed Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 177.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.74 -77.44 0.62 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -178.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.47 92.2 9.02 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 177.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.51 94.77 6.93 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.07 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -139.76 77.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -97.55 70.44 2.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -134.82 -82.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.4 p -128.94 -56.2 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.09 0.956 . . . . 0.0 111.307 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 122.828 1.299 . . . . 0.0 113.784 179.798 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.254 0.9 OUTLIER -109.49 114.69 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 . . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -110.45 10.88 23.25 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.94 86.62 0.45 Allowed Glycine 0 CA--C 1.541 1.68 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.25 -77.83 0.66 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -90.33 93.34 9.29 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 177.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.42 94.13 6.13 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 122.216 1.007 . . . . 0.0 112.746 -177.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -138.89 78.54 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 178.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -95.72 64.9 2.55 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.4 m -141.4 -80.72 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.6 p -95.18 -61.14 1.53 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.128 0.876 . . . . 0.0 112.265 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.849 1.309 . . . . 0.0 110.042 -179.879 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.209 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.86 115.7 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -117.35 12.8 14.39 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.99 92.56 0.52 Allowed Glycine 0 CA--C 1.54 1.608 0 N-CA-C 106.866 -2.493 . . . . 0.0 106.866 177.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.46 -78.07 0.57 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -178.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -89.73 92.37 9.03 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.6 mt -81.46 95.48 7.1 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.114 0.959 . . . . 0.0 112.936 -177.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.51 76.61 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 178.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.43 69.08 1.91 Allowed 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -176.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.5 m -138.4 -81.5 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.8 p -111.63 -64.96 1.22 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.829 0.851 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 122.823 1.297 . . . . 0.0 110.396 -179.769 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.26 99.68 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -102.81 92.46 4.6 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.37 84.77 0.12 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.291 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.384 0.135 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -58.88 0.41 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-O 119.995 -0.336 . . . . 0.0 113.391 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.96 99.5 11.02 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.31 -3.94 12.68 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 118.976 2.954 . . . . 0.0 118.976 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.18 85.04 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -127.25 90.76 3.19 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.044 0.538 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -61.48 -52.95 62.4 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-N 119.678 1.127 . . . . 0.0 112.483 178.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.7 m -132.46 97.88 4.21 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 178.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 124.114 1.912 . . . . 0.0 111.294 -179.789 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.241 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -118.73 99.92 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -101.62 92.12 4.73 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.38 85.68 0.11 Allowed Glycine 0 CA--C 1.536 1.375 0 CA-C-N 115.32 -0.854 . . . . 0.0 114.354 -179.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.733 0.301 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 -58.79 0.82 Allowed Glycine 0 N--CA 1.487 2.037 0 CA-C-O 119.852 -0.415 . . . . 0.0 113.76 -178.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -84.95 99.05 10.73 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.67 -4.33 15.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.03 85.67 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -128.45 92.07 3.36 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -61.46 -54.7 39.95 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 119.696 1.134 . . . . 0.0 112.335 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -132.13 98.45 4.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 178.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.163 1.935 . . . . 0.0 111.223 -179.854 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mm -118.64 99.67 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -101.5 92.15 4.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.91 85.05 0.12 Allowed Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.529 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.345 0.117 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.57 -58.99 0.41 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-O 119.884 -0.398 . . . . 0.0 113.357 -178.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -85.19 99.67 11.24 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.42 -4.44 14.76 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 -179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -126.06 85.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.33 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.01 91.05 3.2 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -61.66 -53.5 55.27 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 119.732 1.151 . . . . 0.0 112.527 178.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.5 m -133.56 98.58 4.24 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 178.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 124.199 1.952 . . . . 0.0 111.1 -179.796 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.231 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -119.19 102.21 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -104.44 92.82 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.71 79.82 0.19 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 114.507 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.09 -74.01 0.21 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -90.87 90.79 8.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.279 1.8 pt? -83.06 58.56 4.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 -178.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 10.0 tp -156.91 75.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -131.38 94.66 3.59 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.1 m -58.72 -53.35 59.32 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-N 119.877 1.217 . . . . 0.0 112.956 178.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.0 m -133.6 98.12 4.12 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 178.445 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.123 1.916 . . . . 0.0 111.223 -179.795 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.265 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.93 85.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 124.37 1.044 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -120.53 72.72 0.97 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 176.191 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.06 -79.59 1.48 Allowed Glycine 0 CA--C 1.547 2.067 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -176.385 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.7 t . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.409 0.147 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.58 -60.15 0.67 Allowed Glycine 0 N--CA 1.487 2.056 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.983 -178.466 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -90.65 93.2 9.16 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.51 -19.82 65.88 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.31 0.3 OUTLIER -90.55 43.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.094 0 CA-C-N 121.909 2.14 . . . . 0.0 113.439 179.557 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.6 -26.14 14.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 117.783 -1.103 . . . . 0.0 113.944 177.819 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.1 m -108.84 -78.45 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.753 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -124.18 -79.31 0.61 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 123.107 1.432 . . . . 0.0 109.244 179.518 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.54 112.19 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -83.44 84.11 7.64 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.46 1.124 . . . . 0.0 109.823 179.273 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.58 -79.67 1.54 Allowed Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.726 -179.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.6 -65.52 0.25 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.022 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.97 95.44 10.12 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.43 -27.65 69.43 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 -178.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.277 0.2 OUTLIER -99.1 70.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 121.905 2.138 . . . . 0.0 111.745 -179.052 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.72 -18.8 13.84 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 177.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -131.91 -77.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 121.367 1.894 . . . . 0.0 106.826 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 p -113.34 -80.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 119.476 1.035 . . . . 0.0 109.678 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 123.007 1.384 . . . . 0.0 112.954 -179.348 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.35 109.32 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -85.46 83.17 8.01 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 122.518 1.151 . . . . 0.0 109.149 178.766 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.41 -78.92 1.6 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.463 -179.371 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.69 -69.13 0.29 Allowed Glycine 0 N--CA 1.488 2.136 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -86.31 93.47 9.1 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.86 -26.63 65.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -177.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.304 0.2 OUTLIER -93.04 62.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 121.868 2.122 . . . . 0.0 112.522 -179.447 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.23 -17.86 14.7 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 178.132 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -134.97 -76.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.099 1.772 . . . . 0.0 106.477 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.9 p -119.56 -80.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.635 1.107 . . . . 0.0 109.372 179.396 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 124.394 2.045 . . . . 0.0 111.107 -179.356 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.68 91.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -82.25 -36.99 26.6 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 117.06 2.245 . . . . 0.0 117.06 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.6 75.76 0.06 OUTLIER Glycine 0 CA--C 1.537 1.455 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.105 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.69 -79.57 1.54 Allowed Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.993 0.815 . . . . 0.0 111.686 -178.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -93.5 99.46 11.93 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 176.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.76 99.2 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.728 -177.708 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -127.14 78.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.26 46.44 1.38 Allowed 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -179.036 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.2 m -148.88 -73.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -86.48 120.36 27.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 123.036 1.398 . . . . 0.0 113.379 -179.771 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 mm -107.75 90.04 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -77.13 -34.02 56.7 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.63 79.28 0.04 OUTLIER Glycine 0 CA--C 1.536 1.345 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 -79.54 1.58 Allowed Glycine 0 N--CA 1.491 2.344 0 CA-C-N 119.098 0.863 . . . . 0.0 111.476 -178.427 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 98.33 11.28 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 176.247 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.01 102.5 3.51 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.016 -178.206 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -125.27 75.5 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.609 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.83 55.96 1.23 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.092 0.957 . . . . 0.0 110.739 -179.667 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -151.19 -70.88 0.17 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 95.7 m -145.4 101.77 3.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 122.955 1.359 . . . . 0.0 111.322 179.999 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.23 99.21 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -85.2 -37.58 19.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -177.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.35 91.73 2.03 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 123.612 0.625 . . . . 0.0 111.783 -179.689 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 -81.02 1.65 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 94.4 6.12 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 175.344 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.24 103.3 2.77 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.176 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.23 78.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.91 65.16 0.8 Allowed 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.781 0.832 . . . . 0.0 110.033 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.8 m -143.49 -78.13 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -145.98 100.79 3.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.408 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 124.336 2.017 . . . . 0.0 108.769 -179.961 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.9 mm -127.15 95.27 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.46 61.61 1.47 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.909 0.861 . . . . 0.0 111.038 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.06 92.97 0.1 Allowed Glycine 0 CA--C 1.544 1.846 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 -81.79 1.47 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.95 95.03 6.88 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -71.98 103.64 3.28 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.42 0.629 . . . . 0.0 112.341 -177.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -110.75 75.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.227 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.96 59.35 2.31 Favored 'General case' 0 CA--C 1.571 1.77 0 C-N-CA 123.86 0.864 . . . . 0.0 112.314 -178.227 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 m -149.88 -82.98 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 179.337 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.7 m -151.36 110.01 3.83 Favored 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 123.002 1.382 . . . . 0.0 111.72 -179.829 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.67 99.19 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -83.81 -37.74 22.15 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -177.79 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.11 83.17 1.3 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 123.557 0.599 . . . . 0.0 113.865 179.554 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.83 -80.62 1.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -178.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.91 97.27 11.08 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 175.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.61 100.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.549 -177.484 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 tp -117.84 88.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 179.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.65 52.64 1.16 Allowed 'General case' 0 CA--C 1.572 1.824 0 C-N-CA 123.778 0.831 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -145.96 -74.35 0.22 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.1 m -143.69 101.91 3.84 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 179.119 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 124.147 1.927 . . . . 0.0 110.215 -179.952 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.199 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm -122.75 102.63 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -128.12 77.11 1.74 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.789 0.804 . . . . 0.0 108.953 179.037 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.17 85.33 0.09 OUTLIER Glycine 0 CA--C 1.542 1.764 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.03 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.55 -76.31 2.25 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -177.963 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.6 100.21 12.2 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.643 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.25 104.74 2.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.095 -179.017 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.25 84.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.833 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -89.63 67.59 7.49 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 121.743 -0.598 . . . . 0.0 111.28 -179.155 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.8 m -126.88 -78.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 108.354 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -140.07 92.47 2.55 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 179.592 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.943 1.354 . . . . 0.0 109.918 179.85 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.23 94.83 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -119.86 72.02 0.91 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.482 1.134 . . . . 0.0 109.16 178.375 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.1 92.98 0.08 OUTLIER Glycine 0 CA--C 1.541 1.692 0 CA-C-N 114.352 -1.295 . . . . 0.0 116.144 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.49 -75.9 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.329 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.28 101.18 13.43 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 177.016 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.99 104.64 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.689 -178.979 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.22 82.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.461 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -89.03 66.44 7.82 Favored 'General case' 0 CA--C 1.572 1.796 0 O-C-N 121.758 -0.589 . . . . 0.0 111.406 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.2 m -108.41 -79.06 0.58 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.988 -1.07 . . . . 0.0 109.561 -179.228 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.2 m -145.97 118.72 8.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.759 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 122.899 1.333 . . . . 0.0 109.614 179.584 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm -104.57 91.68 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -94.89 -2.24 51.05 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -179.15 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.51 85.88 0.16 Allowed Glycine 0 CA--C 1.536 1.379 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.711 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.33 -76.77 2.16 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.374 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.23 103.23 15.26 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 177.243 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.47 103.11 1.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.409 -178.586 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.2 tp -139.74 84.25 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.621 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -88.67 75.4 8.24 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.703 -0.623 . . . . 0.0 109.874 -178.999 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -87.02 -81.85 0.22 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.968 -1.083 . . . . 0.0 110.866 -179.554 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -147.59 135.47 21.15 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.339 0.972 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 123.064 1.411 . . . . 0.0 112.316 179.407 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.57 109.9 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.341 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -83.62 -23.2 31.97 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 179.549 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.29 -78.43 0.96 Allowed Glycine 0 N--CA 1.481 1.666 0 CA-C-N 118.728 0.694 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.53 -72.56 0.5 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.027 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -88.39 97.25 10.95 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 177.871 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.89 56.13 3.78 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 123.02 1.39 . . . . 0.0 113.233 179.702 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 tp -167.95 71.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 178.658 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -111.16 -56.53 2.36 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 116.479 -1.724 . . . . 0.0 114.999 -176.955 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -157.57 -78.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.787 2.54 . . . . 0.0 107.709 -178.976 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.7 m -77.4 132.16 38.38 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.751 0.82 . . . . 0.0 110.702 -179.081 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -179.569 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.65 117.32 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -73.25 -36.08 66.33 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 178.639 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.08 -76.55 1.82 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 123.834 0.73 . . . . 0.0 114.834 179.29 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.46 -71.03 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -178.848 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -86.24 98.13 10.76 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.948 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 mt -61.74 -21.39 64.49 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 -179.568 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 tp -101.42 74.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 121.715 2.052 . . . . 0.0 107.8 177.811 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -115.97 -41.81 3.14 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.238 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.5 m -135.88 -86.18 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 122.951 2.614 . . . . 0.0 110.164 -177.985 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 m -134.7 141.54 46.56 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.758 1.163 . . . . 0.0 110.425 -177.792 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 122.769 1.271 . . . . 0.0 113.42 179.723 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.87 116.6 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -72.36 -33.09 67.0 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.01 -75.33 1.07 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 123.56 0.6 . . . . 0.0 113.663 179.954 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.99 -71.97 0.54 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.21 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.65 91.37 8.72 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 177.198 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -85.81 59.76 5.83 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 tp -155.21 65.43 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -133.66 -22.31 1.91 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -177.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.5 m -142.71 -84.31 0.17 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 123.256 2.753 . . . . 0.0 109.797 -178.163 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 m -137.45 144.73 42.46 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 119.731 1.151 . . . . 0.0 110.533 -177.719 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 122.813 1.292 . . . . 0.0 113.203 179.436 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.73 108.71 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.383 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -77.96 -18.72 55.69 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 179.01 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.49 -78.64 0.24 Allowed Glycine 0 N--CA 1.481 1.681 0 C-N-CA 124.034 0.826 . . . . 0.0 111.865 -179.561 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.068 0.461 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.32 -74.53 0.5 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.423 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -88.17 92.01 8.99 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.537 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.85 64.65 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.223 1.011 . . . . 0.0 112.885 -178.796 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 tp -167.63 73.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 179.293 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -128.62 -34.09 2.02 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -178.126 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 p -143.99 -86.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 123.294 2.77 . . . . 0.0 107.43 -178.985 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.9 m -149.17 137.11 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.329 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 122.981 1.372 . . . . 0.0 112.197 179.032 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.06 116.1 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.89 -34.15 64.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.07 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.83 -75.23 0.94 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 123.539 0.59 . . . . 0.0 113.651 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.033 0.444 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.15 -72.06 0.53 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -178.331 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -87.61 91.56 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.262 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.95 60.21 6.1 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.348 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 tp -155.73 65.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.258 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -134.25 -22.34 1.77 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 118.285 2.698 . . . . 0.0 118.285 -177.844 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 m -141.93 -83.8 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 123.441 2.837 . . . . 0.0 109.906 -178.15 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.3 m -136.74 143.92 43.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 119.669 1.122 . . . . 0.0 110.608 -177.686 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 122.798 1.285 . . . . 0.0 113.256 179.491 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.72 111.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -89.57 -40.64 12.49 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -179.161 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.28 60.51 8.9 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.043 1.577 . . . . 0.0 117.043 179.714 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.14 -75.54 1.9 Allowed Glycine 0 N--CA 1.485 1.9 0 N-CA-C 113.656 0.222 . . . . 0.0 113.656 -179.866 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -87.13 90.07 8.23 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.511 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.4 mt -80.98 82.67 6.89 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.848 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.256 11.0 tp -161.51 75.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 C-N-CA 123.794 0.838 . . . . 0.0 108.957 178.699 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -139.63 97.63 3.31 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.461 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -56.08 -41.22 74.79 Favored 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 -179.873 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.1 p -68.52 -46.88 68.42 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 178.748 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 179.288 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.3 109.58 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -85.9 -15.72 40.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -179.718 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.42 1.38 Allowed Glycine 0 N--CA 1.484 1.899 0 CA-C-N 118.926 0.785 . . . . 0.0 114.147 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.5 -76.73 1.87 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.874 0.71 . . . . 0.0 114.874 179.439 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -96.87 95.96 8.21 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.128 0.971 . . . . 0.0 108.827 -179.384 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.78 88.97 5.21 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.483 -179.513 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.253 11.3 tp -151.56 73.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.752 0.786 . . . . 0.0 108.882 179.101 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -128.37 72.94 1.45 Allowed 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.413 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.2 m -68.12 -63.73 1.0 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.187 -0.945 . . . . 0.0 111.857 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.4 p -98.48 87.94 3.98 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.156 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 124.371 2.034 . . . . 0.0 110.587 -179.378 . . . . . . . . 0 0 . 1 stop_ save_